Treatment of Proliferative Disorders Using Antibodies to PSMA
AssigneeCornell University
InventorNeil H. Bander
Life of this patent
Estimating the term…
Abstract
Methods of treating cancer in a patient are provided. In some embodiments the method comprises administering an antibody that is capable of binding to the extracellular domain of PSMA after first administering a hormonal therapy.
Claims15
1-14. (canceled)
A method of treating a prostate cancer in a patient in need thereof comprising administering an antibody or antigen binding fragment thereof that is capable of binding to an extracellular domain of PSMA wherein the antibody or antigen binding fragment is conjugated to Lutetium-177 or other short range isotope wherein a first dose of the antibody or antigen binding fragment thereof is administered to the patient two to four weeks after beginning administration of hormonal therapy to the patient.
Dependencies are inferred from the claim text.